Fortis to divest stake in Singapore-based RadLink

Malaysia's IHH Healthcare Bhd will buy the assets for about $108.5 million

Don't want to miss the best from Business Standard?

Fortis Healthcare Singapore Pte Ltd, a subsidiary of Fortis Healthcare International, is divesting all its stake in diagnostic and molecular imaging unit RadLink-Asia Pte Ltd, the parent company said in a statement on Friday.

Malaysia's IHH Healthcare Bhd, Asia's largest hospital operator by stock market value, will buy the assets for 137 million Singaporean dollars (around $108.5 million).

"The deal will be successfully closed following the necessary statutory and regulatory approvals as per local requirements," Fortis said.

J P Morgan and Religare Capital Markets acted as financial advisors to Fortis for this transaction.

Fortis, which is on a selling-spree since 2013, is planning to focus on India now. The company is also in the process of expanding its hospital chain across the domestic market. During fiscal year 2014, Fortis added over 800 beds to its network in India. In May 2013, it launched the Fortis Memorial Research Institute in Gurgaon and in January 2014, it commissioned a 260 bed facility in Ludhiana. A large facility in Chennai (Arcot Road) is also nearing completion and is expected to be commissioned in the next few months.

Malvinder Singh, Executive Chairman, and Shivinder Singh, Executive Vice Chairman, Fortis Healthcare Limited, said "This is in line with our strategic decision to intensify our focus on our core hospital and diagnostics business in India. Our international healthcare businesses have all done well. The significant value that we have created, is now being unlocked and will be ploughed back to strengthen our growth in India."